Related Experiment Video
Updated: Aug 8, 2026

Creating Radio-cephalic Arteriovenous Fistula in the Forearm with a Modified No-Touch Technique
Published on: April 1, 2022
Maintenance and salvage of arteriovenous fistulas
1Access Ambulatory Center, Brooklyn, New York 10025, USA. abigailfalk123@pol.net
Insights
Percutaneous interventions are crucial for hemodialysis fistula maturation and patency. However, many procedures are needed, and not all nonmaturing fistulas become functional.
Area of Science:
- Vascular Surgery
- Nephrology
- Interventional Radiology
Background:
- Arteriovenous fistulas are essential for hemodialysis access.
- Maturation and patency of these fistulas can be challenging.
- Percutaneous interventions are frequently employed to address these issues.
Purpose of the Study:
- To quantify the number and types of percutaneous interventions required for hemodialysis fistula maturation.
- To assess the interventions needed for maintaining fistula patency.
- To evaluate the effectiveness of percutaneous procedures in achieving functional vascular access.
Main Methods:
- Retrospective review of 154 hemodialysis fistulas created in 146 patients.
- Analysis of all percutaneous procedures performed to promote maturation and maintain patency.
- Assessment of fistula patency using medical records from hemodialysis centers.
Main Results:
- 113 procedures were performed on 65 nonmaturing fistulas (1.7/fistula), with 74% becoming functional.
- 63 mature fistulas required 209 procedures (3.3/fistula) to maintain patency.
- Primary patency rates at 360 days were 64%, with secondary patency at 68%.
Conclusions:
- Percutaneous procedures play a significant role in promoting maturation and maintaining patency of arteriovenous fistulas.
- Despite interventions, a notable percentage of nonmaturing fistulas do not achieve functionality.
- Ongoing percutaneous interventions are necessary for sustained fistula patency in hemodialysis patients.
Purpose:
To describe the number and type of percutaneous interventions required to promote maturation and maintain patency of hemodialysis fistulas.
Materials And Methods:
One hundred fifty-four hemodialysis fistulas were created in 146 patients by a single surgeon between August 2001 and March 2005. There were 88 male patients (60%), and the median age of the group was 66 years. The records of all percutaneous procedures performed on these patients were retrospectively reviewed. The medical records from the hemodialysis treatment centers were also reviewed to assess fistula patency during the follow-up period.
Results:
Of the initial 154 fistulas created, 112 (73%) were successfully used for hemodialysis. One hundred thirteen procedures were performed to promote maturation of 65 fistulas (1.7 procedures per fistula), including 66 venous angioplasty procedures, 16 arterial angioplasty procedures, ligation of 21 venous side branches, five thrombectomy procedures, three banding procedures, and two other procedures. Only 48 of these nonmaturing fistulas (74%) became functional. Sixty-three mature fistulas required 209 procedures (3.3 procedures per fistula, 1.75 procedures per access-year) to maintain vascular access patency. These included 174 venous angioplasty procedures, 18 arterial angioplasty procedures, 14 thrombectomy procedures, ligation of three venous side branches, and two stent placement procedures. The mean follow-up period for all 154 fistulas was 317 days (range, 12-1,138 days). Primary patency rates at 90, 180, and 360 days were 71%, 69%, and 64%, respectively, and secondary patency rates were 73%, 72%, and 68%, respectively.
Conclusions:
Percutaneous procedures can promote maturation and maintain patency of arteriovenous fistulas. However, despite numerous procedures to promote maturation, only 74% of nonmaturing fistulas became functional.
Related Concept Videos
Hemodialysis I: Introduction
Peripheral Artery Disease V: Postoperative Nursing Management
Aneurysm III: Interprofessional Care
Continuous Renal Replacement Therapy
Aneurysm IV: Nursing Management
Peripheral Artery Disease III: Interprofessional Care
